Diploma (LON:DPLM - Get Free Report) was upgraded by stock analysts at Royal Bank Of Canada to an "outperform" rating in a report issued on Friday,Digital Look reports. The firm presently has a GBX 6,000 price target on the stock, up from their prior price target of GBX 4,500. Royal Bank Of Canada's price target indicates a potential upside of 12.04% from the company's previous close.
A number of other equities research analysts also recently weighed in on DPLM. Berenberg Bank raised their target price on shares of Diploma from GBX 5,750 to GBX 6,350 and gave the company a "buy" rating in a research note on Wednesday, September 10th. Jefferies Financial Group boosted their target price on Diploma from GBX 4,500 to GBX 5,200 and gave the stock a "hold" rating in a research report on Thursday, September 11th. Shore Capital reissued a "hold" rating and issued a GBX 5,100 price target on shares of Diploma in a research note on Thursday, July 17th. Finally, JPMorgan Chase & Co. reiterated a "neutral" rating and issued a GBX 4,440 price objective on shares of Diploma in a research report on Wednesday, August 6th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Diploma has an average rating of "Moderate Buy" and an average target price of GBX 5,365.
Read Our Latest Analysis on Diploma
Diploma Trading Up 1.9%
Shares of DPLM stock opened at GBX 5,355 on Friday. Diploma has a 52-week low of GBX 3,532 and a 52-week high of GBX 5,625. The business's fifty day moving average is GBX 5,384.87 and its 200 day moving average is GBX 4,730.93. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. The company has a market capitalization of £7.18 billion, a PE ratio of 4,308.13, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.